Helsinn and Fosun Pharma sign exclusive license and distribution agreements for Aloxi®, Akynzeo® oral, NEPA IV and anamorelin in Mainland China, Hong Kong SAR and Macau SAR
Helsinn and Fosun Pharmasign exclusive license and distribution agreementsfor Aloxi®, Akynzeo®oral, NEPA IV and anamorelin in Mainland China, Hong Kong SAR and Macau SAR
Lugano, Switzerland Shanghai, China,October 12, 2021- Helsinn Group (Helsinn), a Swiss…
